retatrutide women The next Ozempic? New weight-loss drug shows promising results Retatrutide: The Future of GLP-1
Description
Peters H, Potla P, Rockel JS, Tockovska T, Pastrello C, Jurisica I, et al
Tosin observed
[00:10:42] Emily Field: Now heres where the GLP one medications add an interesting wrinkle to this conversation
It slows the emptying of the stomach, allowing you to feel satisfied with smaller portions
The GIP receptor pathway, popularized by tirzepatide's dual agonist approach, adds another layer of metabolic optimization through its effects on both glucose homeostasis and lipid metabolism
One thing is clear: GLP-1s are already immensely popular among the public, and costing provincial drug plans a fair amount
